Press Releases

When virologists become reality TV stars, biologists dream of life without illness, researchers debate organoids vs. animal testing with the general public, and biomedical scientists discuss the possibilities of AI, it can only be Berlin Science Week. This year, the MDC is holding a number of virtual events.

The Berlin biotech start-up T-knife, a spin-off from the MDC together with Charité, has secured investments totaling €66 million. Four venture capital funds committed to the financing in early August. T-knife develops new cancer treatments using modified immune system T cells.

The board of the Einstein Foundation approved the preliminary stage of a new Einstein Center for the development of alternative methods for animal testing in biomedical research. The aim of the planned center is to reduce or replace animal experiments. It will be established in cooperation with the MDC.

Thomas Blankenstein receives an ERC Advanced grant for cancer research. The scientist wants to find out if T cells control the development of cancer by a process called immunosurveillance. For this purpose he now proposes a new research model.

The Käthe-Beutler-Haus of the BIH is currently being built on the Berlin-Buch campus - the Medizinhistorische Journal now reports on the life of the Jewish paediatrician, researcher and mother.

Criticism is an essential part of science. However, the personal vilification and blanket denunciation of researchers is not acceptable. Here is the MDC’s statement on the current campaign of Doctors Against Animal Experiments Germany.